Continued funding from all countries needed to fight HIV/AIDS

NewsGuard 100/100 Score

"There is no doubt that" a 10 percent reduction in funding from donor governments for the AIDS response in low- and middle-income countries in 2010 from the previous year's levels "is linked to economic strain felt by countries across the globe," a VOA News editorial says. "UNAIDS estimates that an investment of at least $22 billion will be needed by 2015 in order to avert more than seven million deaths," the editorial states, adding, "It is clear that continued support to HIV prevention and treatment is a necessary investment, even in these difficult times."

According to the editorial, "The United States remains the global leader in fighting HIV/AIDS, providing 54 percent of all donor government funds for global HIV/AIDS. Through the President's Emergency Plan for AIDS Relief, or PEPFAR, the U.S. has committed to support treatment for more than four million people, prevention of more than 12 million new HIV infections and care for more than 12 million people. But saving lives must be a shared responsibility. It is critical that all countries step up to the plate to reach ambitious and aggressive goals," VOA concludes.


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unveiling the key role of RNA modification in HIV-1 survival and replication